CME webinar: Screening and Assessment for Suicide Prevention

Sep. 2022Education/Webinars
"September is National Suicide Awareness Month, and you are invited to watch a timely recorded webinar on the topic. Andrei Nemoianu, MD, Regional Medical Director, Community Care Behavioral Health Organization, discusses:
  • How to define suicide screening and identify how often it should be used.
  • Suicide assessment and when it should be done.
  • How to gain greater familiarity with formulating a suicide risk assessment.
  • Three suicide screening tools.
  • How to locate resources to help develop a policy around suicide screening and assessment.
Register or log in to listen to the webinar. You may earn continuing medical education credits (CME) for watching this webinar.*

*This activity is approved for AMA PRA Category 1 Credit™ and ANCC. Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
*Provider is responsible for verifying CME eligibility."

Recent Announcements

Clinical workflow changes through Epic®

Changes are coming for network providers that utilize Provider OnLine to submit specific information to UPMC Health Plan. Select activities that were previously completed in Provider OnLine will now transition to UPMC Health Plan Tapestry Link.
Sep. 2026Important Notices

CME Webinar: Lifestyle Medicine in Practice: Evidence‑Based Strategies for Chronic Disease Care

Please join us for a live, CME-accredited webinar on Wednesday, Sept. 23 from noon to 1 p.m., that will provide an overview on lifestyle medicine. Participants will learn how to integrate six core domains—nutrition, physical activity, sleep, stress management, avoidance of risky substances, and social connection—into routine care using practical tools such as brief counseling, motivational interviewing, and team-based strategies.
Sep. 2026Education/Webinars

Voluntary nationwide recall: Thyroid (Vitruvias – August 2026)

Vitruvias Therapeutics Inc. is recalling one lot, lot 504950, of Thyroid Tablets, USP 30 mg. Thyroid Tablet is used to treat hypothyroidism (underactive thyroid).
Sep. 2026Pharmacy Updates